Arbutus expects to receive around $179 million from Moderna.

Abus Magomedov defeated Michal Oleksiejczuk by SUB, round 1 on 27 June 2026. Full result, reaction and what's next.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Arbutus Biopharma (ABUS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Abusupiyan Magomedov has been been developing himself in the middleweight division of the Ultimate Fighting Championship (UFC). Hailing from Dusseldorf, Germany, he has racked up wins mostly using TKO ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.